Further molecular mechanism investigation indicated that TXNDC5 was downregulated by decreasing m6A-levels after METTL3 knockdown and ultimately inhibiting the progression of primary acral melanoma. The gene discussed is METTL3; the disease is acral lentiginous melanoma.